{ "items": [ "\n\n
\n \n 2 September 2020\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nEvotec SE, a drug discovery and development solutions company, today announced a partnership agreement with the University of Oxford regarding access to biospecimens from the biobank Quality in Organ Donation (QUOD), an initiative of the Nuffield Department of Surgical Sciences (NDS) at the University of Oxford in close collaboration with the National Health Service Blood and Transplant (NHSBT) organisation in the UK.
\n \n\n\n \n 4 August 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards and Appointments\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThere is an increasing body of genetic and biochemical evidence that points toward lysosomal dysfunction as a risk factor for developing age-related neurodegenerative disorders, including Parkinson\u2019s disease (PD).
\n \n\n\n \n 16 July 2020\n \n
\n\n \n\n \n\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThree companies at Oxford\u2019s BioEscalator are developing new detection methods and have discovered potential therapeutics in the fight against COVID-19.
\n \n\n\n \n 3 July 2020\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nUK Research and Innovation, Cancer Research UK and industry are investing more than \u00a311 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases.
\n \n\n\n \n 2 July 2020\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe European Commission has granted Marketing Authorisation to Janssen for a new Ebola vaccine, developed in partnership with the University of Oxford.
\n \n\n\n \n 24 June 2020\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nFollowing a fantastic event, Theolytics was announced the winner of the BioEscalator\u2019s inaugural Pitch Finale, which was kindly supported by Santander Universities UK.
\n \n\n\n \n 16 June 2020\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Capture the Fracture Partnership aims to prevent 250 million fractures by 2025 and combat the global public health burden of osteoporosis.
\n \n\n\n \n 8 June 2020\n \n
\n\n \n\n \n\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nA team of radiologists and radiographers at Oxford University Hospitals and University of Oxford's Department of Oncology has secured a grant to customise a teaching platform to educate frontline NHS staff to diagnose COVID-19 using chest X-rays and CT scans.
\n \n\n\n \n 12 May 2020\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nThe BioEscalator\u2019s inaugural Pitch Battle contest was held digitally at the pizza social on Friday 17 April. Eleven pitches in total were delivered by innovative companies in Oxford's medical research district, covering the broad range of drug discovery, drug development and diagnostics work being undertaken at the BioEscalator.
\n \n\n\n \n 30 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford has today announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the University.
\n \n\n\n \n 1 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nSystem being used in John Warin isolation ward at Oxford's John Radcliffe Hospital
\n \n\n\n \n 5 March 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards and Appointments\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Nessa Carey will lead the strategic development and implementation of the Entrepreneur in Residence (EiR) programme in Medical Sciences, laying the foundation of a world-class innovation support ecosystem capable of accelerating the translation of world-leading research into innovative therapies, business and commercial products.
\n \n\n\n \n 23 January 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards and Appointments\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nTwo University of Oxford alumni-led startups, iLoF and Pipra, secured funding in excess of \u20ac4M from the European Institute of Technology for Health (EIT Health).
\n \n\n\n \n 14 January 2020\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nUp to 30,000 lives could be saved over the next decade thanks to a proposed pioneering government collaboration with pharmaceutical company Novartis to tackle heart disease \u2013 a leading cause of death in the UK.
\n \n\n\n \n 7 February 2019\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nGenesisCare and the University of Oxford establish innovative 10-year research partnership to improve diagnosis and care for people with cancer.
\n \n\n\n \n 4 February 2019\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford University, through its innovation arm Oxford University Innovation (OUI), has entered into an option agreement for a universal influenza vaccine with US-based startup Blue Water Vaccines (BWV), which is raising $15m to support development of the flu shot.
\n \n\n\n \n 1 February 2019\n \n
\n\n \n\n \n\n \n \n \n \n Awards and Appointments\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nTen innovative data solutions to healthcare challenges, including a project led by the Head of the Nuffield Department of Surgical Sciences (NDS), Professor Freddie Hamdy, are set to receive a share of \u00a33 million Government funding following a UK-wide competition. The initiatives will see NHS, universities and companies combining expertise and using health data responsibly to drive innovation and improve health outcomes for people across the UK.
\n \n\n\n \n 10 January 2019\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford University Innovation Incubator unveils with new deal on equity and access to finance through the OUI Future Fusion programme.
\n \n\n\n \n 2 January 2019\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford University\u2019s Medical Sciences Business Development & Partnering team reflect on 2018 and look forward to 2019
\n \n\n\n \n 4 December 2018\n \n
\n\n \n\n \n\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe UK\u2019s first dedicated Vaccines Manufacturing Innovation Centre (VMIC), announced by Business Secretary Greg Clark MP, represents a major commercial opportunity and also a new front line in the nation\u2019s defence against global pandemic threats.
\n \n\n